Organogenesis (ORGO) investor relations material

Opening remarks and agenda

• The meeting was called to order by the Chair, who welcomed attendees to the 2026 virtual annual meeting and introduced the board and management team members present virtually.

• The agenda included the election of directors, advisory vote on executive compensation, and ratification of the independent auditor.

Board and executive committee updates

• The board consists of nine nominees for re-election and one preferred director, totaling ten directors for the next term.

• No other nominations for director positions were received from stockholders.

Shareholder proposals

• No additional matters or proposals were submitted by stockholders for consideration at the meeting.